Evidence map›Paper›PMID 39867704›Full record

ArticleHealth science reports2025

Exploring the Epidemiological Characteristics and Survival Analysis Among Prostate Cancer Patients Under 50: A Seer-Based Population Study.

Bahaa Mali, Ali Mali, Alaa Mali, Mohammed Abdulrazzak, Afnan W M Jobran

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bahaa MaliFaculty of Medicine Al Quds University Jerusalem Palestine.ORCID 0009-0001-2845-1378
Ali MaliFaculty of Medicine Al Quds University Jerusalem Palestine.ORCID 0009-0000-7939-3625
Alaa MaliFaculty of Medicine Al Quds University Jerusalem Palestine.ORCID 0009-0006-1415-1450
Mohammed AbdulrazzakFaculty of Medicine University of Aleppo Aleppo Syria.ORCID 0000-0003-0807-9000
Afnan W M JobranFaculty of Medicine Al Quds University Jerusalem Palestine.ORCID 0000-0003-1068-2984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Even though aging is a known risk factor for prostate cancer incidence and mortality, there has been an increase in incidence among young men since the late 1980s with notably lower survival rates than those among older men. However, there is insufficient knowledge about recent trends in the incidence and survival of this disease. Methods: We analyzed prostatic cancer incidence trends in men under 50 from 1975 to 2020 using Surveillance, Epidemiology, and End Results (SEER) 8 registries data. We further studied frequency, incidence rate, and survival rates in this group across SEER 22 registries, which cover around 41.9% of the US population. We analyzed the data by age, stage, and race subgroups and identified potential risk factors affecting survival prognosis using multivariable Cox proportional hazards regression models. Results: Our results revealed that prostate cancer incidence rates in men under 50 have increased from 1975 to 2020. There was a significant decline from 2009 to 2014, followed by a gradual decrease. Between 2004 and 2020, 35,670 new cases were diagnosed. 76.10% of these cases were localized, 15.10% were regional, 4.20% were distant, and 4.60% were unstaged. Certain factors can negatively impact the prognosis, including age at diagnosis under 30, advanced stages of the disease, and non-Hispanic black race. Conclusion: Early-onset prostate cancer has distinct epidemiological and clinical characteristics, and more research is required to gain a better understanding of the biological, genetic, and environmental factors that contribute to its development. This understanding will assist in the creation of more suitable management plans that can enhance survival rates.

Indexed as

incidence ratesprostate cancerSEERsurvival ratesyoung men

Identifiers

PMID39867704
PMCPMC11758148

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.